<DOC>
	<DOCNO>NCT03071679</DOCNO>
	<brief_summary>This study randomize , evaluator-blinded , vehicle- control study ass pharmacodynamics omiganan omiganan imiquimod healthy volunteer .</brief_summary>
	<brief_title>Topical Challenge With Omiganan Imiquimod Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Healthy male female subject , 18 45 year age , inclusive . Healthy status define absence evidence active chronic disease follow detailed medical surgical history , complete physical examination include vital sign , 12lead ECG , haematology , blood chemistry , blood serology urinalysis . Body mass index ( BMI ) 18 30 kg/m2 , inclusive , minimum weight 50 kg . Fitzpatrick skin type IIII ( Caucasian ) Subjects partner childbearing potential must use effective contraception , duration study 3 month last dose . Able willing give write informed consent comply study restriction . Any disease associate immune system impairment , include autoimmune disease , HIV transplantation patient Family history psoriasis History pathological scar formation ( keloid , hypertrophic scar ) Have current / recurrent pathologically , clinical significant skin condition . Previous use imiquimod/ resiquimod/ gardiquimod Known hypersensitivity ( non ) investigational drug , drug class , excipients . Hypersensitivity dermatological marker screen Requirement immunosuppressive immunomodulatory medication within 30 day prior enrollment plan use course study . Use topical medication ( prescription overthecounter [ OTC ] ) within 30 day study drug administration , less 5 halflives ( whichever longer ) local treatment area Tanning due sunbathing , excessive sun exposure tan booth within 3 week enrollment . Participation investigational drug device study within 3 month prior screen 4 time year . Loss donation blood 500 mL within three month ( male ) four month ( female ) prior screen Pregnant , positive pregnancy test , intend become pregnant , breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>